A positive surprise is on the way: Rhythm Pharmaceuticals Inc. (RYTM) Stock
BofA Securities lowered the price target for the Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock from “a Buy” to “a Neutral”. The rating was released on May 08, 2024, according to finviz. We previously noted in another research note published on December 19, 2023 by Morgan Stanley that upgraded the stock from an Equal-weight to an Overweight […]
With upside potential, Rhythm Pharmaceuticals Inc. (RYTM) Stock is well-positioned to grow
BofA Securities lowered the price target for the Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock from “a Buy” to “a Neutral”. The rating was released on May 08, 2024, according to finviz. We previously noted in another research note published on December 19, 2023 by Morgan Stanley that upgraded the stock from an Equal-weight to an Overweight […]
Rhythm Pharmaceuticals Inc. (RYTM) Stock is expected to generate profits in the near future
BofA Securities lowered the price target for the Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock from “a Buy” to “a Neutral”. The rating was released on May 08, 2024, according to finviz. We previously noted in another research note published on December 19, 2023 by Morgan Stanley that upgraded the stock from an Equal-weight to an Overweight […]
Rhythm Pharmaceuticals Inc. (RYTM) Stock: Values And Value Intersection
BofA Securities lowered the price target for the Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock from “a Buy” to “a Neutral”. The rating was released on May 08, 2024, according to finviz. We previously noted in another research note published on December 19, 2023 by Morgan Stanley that upgraded the stock from an Equal-weight to an Overweight […]
Is it possible to sustain this rally? Rhythm Pharmaceuticals Inc. (RYTM) Stock
BofA Securities lowered the price target for the Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock from “a Buy” to “a Neutral”. The rating was released on May 08, 2024, according to finviz. We previously noted in another research note published on December 19, 2023 by Morgan Stanley that upgraded the stock from an Equal-weight to an Overweight […]
The high-quality value of Rhythm Pharmaceuticals Inc. (RYTM) Stock is hidden beneath the surface
BofA Securities lowered the price target for the Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock from “a Buy” to “a Neutral”. The rating was released on May 08, 2024, according to finviz. We previously noted in another research note published on December 19, 2023 by Morgan Stanley that upgraded the stock from an Equal-weight to an Overweight […]
A fresh round of sideways trading continues for Rhythm Pharmaceuticals Inc. (RYTM) Stock.
BofA Securities lowered the price target for the Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock from “a Buy” to “a Neutral”. The rating was released on May 08, 2024, according to finviz. We previously noted in another research note published on December 19, 2023 by Morgan Stanley that upgraded the stock from an Equal-weight to an Overweight […]
There is no better tap than Rhythm Pharmaceuticals Inc. (RYTM) Stock
BofA Securities lowered the price target for the Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock from “a Buy” to “a Neutral”. The rating was released on May 08, 2024, according to finviz. We previously noted in another research note published on December 19, 2023 by Morgan Stanley that upgraded the stock from an Equal-weight to an Overweight […]
